ArticleBlood advances2025
Mitapivat metabolically reprograms human β-thalassemic erythroblasts, increasing their responsiveness to oxidation.
Angela Siciliano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it